aspsirna0171 details

Purple = Wild vs mutant target sequence along with mutation information
Brown= Wild vs ASP-siRNA description along with positional differnece between two
Light pink= ASP siRNA efficacy for mutant vs wild allele
Green= Wild siRNA efficacy for Wild vs Mutant allele
siRNA Id:aspsirna0171
siRNA Name: K12-L132P-1
Gene:Keratin 12 (KRT12)
Disease:Meesmann epithelial corneal dystrophy (MECD)
Wild allele/target (5'->3'): AAGAAACUAUGCAAAAUCU
Mutant allele/target (5'->3'):AAGAAACUAUGCAAAAUCC
Target Mutation: c.409G>C,p.Ala137Pro
Wild siRNA (As strand):UUCUUUGAUACGUUUUAGA
ASP-siRNA (As strand):UUCUUUGAUACGUUUUAGG
Mismatch position in siRNA: G1A
Mutant allele (5'->3'): AAGAAACUAUGCAAAAUCC
ASP-siRNA (As strand):UUCUUUGAUACGUUUUAGG
ASP-siRNA efficacy for mutant allele:74
Wild allele (5'->3'): AAGAAACUAUGCAAAAUCU
ASP-siRNA (As strand):UUCUUUGAUACGUUUUAGG
ASP-siRNA efficacy for wild allele:67
Percentage discrimination for ASP-siRNA:7
Wild allele (5'->3'): AAGAAACUAUGCAAAAUCU
Wild siRNA (As strand):UUCUUUGAUACGUUUUAGA
Wild sirna efficacy for wild allele:78
Wild allele (5'->3'): AAGAAACUAUGCAAAAUCU
ASP-siRNA (As strand):UUCUUUGAUACGUUUUAGG
Wild sirna efficacy for mutant allele:24
Percentage discrimination for wild siRNA:54
Concentration:0.01–6.25nM
Orientation:Sense
Mismatch in:siRNA
UniProt ID: Q99456
Target sequence: TCTGGATCAGAAAAAGAAACTATGCAAAATCTTAATGATAGAT
Genbank Accesion: NM_000223.3
Cell-line: Ptk2
Experimental technique used: Dual luciferase reporter assay
Transfection method: Lipofectamine 2000
siRNA expression method: MWG Biotech AG
Post-transfection duration: 48 hours
OMID ID: 122100
KEGG disease ID:H00726
Reference:22174841

.
.
.
.
.
.
.
.
.
.
.

.

.

.